Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including OmicronHuan Ma, Tengchuan Jin, Xinghai Zhang et al.|Cell Research|2022Cited by 41
A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administrationHuan Ma, Sandra Chiu, Xinghai Zhang et al.|Cell Discovery|2022Cited by 37
An engineered bispecific nanobody in tetrameric secretory IgA format confers broad neutralization against SARS-CoV-1&2 and most variantsWeihong Zeng, Tengchuan Jin, Xiaoying Jia et al.|International Journal of Biological Macromolecules|2023Cited by 12
SARS-CoV-2 N protein-induced Dicer, XPO5, SRSF3, and hnRNPA3 downregulation causes pneumoniaYuwei Luo, Kai‐Fu Tang, Yunfang Bai et al.|Nature Communications|2024Cited by 9
Lymphocyte subset is more suitable than systemic inflammatory response biomarker and immunoglobulin in constructing prognostic nomogram model for advanced gastric cancerTianyi Fang, Yingwei Xue, Xin Yin et al.|Heliyon|2023Cited by 3